Abstract
The performance characteristics of HIV rapid diagnostic tests (RDTs) vary by test and by population. We assessed five commercial RDTs in Uganda where all but one RDT (Determine; Abbott Laboratories, Germany) performed close to manufacturer's expectations. Determine had low specificity (85.2%, positive predictive value 67.3%) due to false-positive results with weakpositive bands. Properly trained staff, good quality control programmes and validation of RDTs with laboratories having confirmatory testing capacity may be warranted to assure accuracy in each setting.
Original language | English (US) |
---|---|
Pages (from-to) | 308-309 |
Number of pages | 2 |
Journal | International Journal of STD and AIDS |
Volume | 22 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2011 |
Externally published | Yes |
Keywords
- HIV
- Point of care tests
- Rapid diagnostic testing
- Resource-poor settings
- Uganda
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Pharmacology (medical)
- Infectious Diseases
- Dermatology